Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group.

scientific article

Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.DLD.2014.02.012
P698PubMed publication ID24630947
P5875ResearchGate publication ID260806593

P50authorFabio PiscagliaQ56455168
Sara MarinelliQ85213523
P2093author name stringEleonora Terzi
Luigi Bolondi
Rita Golfieri
Ilaria Serio
Simona Leoni
Francesca Benevento
Irene Pettinari
Luca Croci
P433issue6
P921main subjectBolognaQ1891
hepatocellular carcinomaQ1148337
P304page(s)549-555
P577publication date2014-03-14
P1433published inDigestive and Liver DiseaseQ15766194
P1476titleAdherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group
P478volume46

Reverse relations

cites work (P2860)
Q41570050Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
Q38697243Advances in Local and Systemic Therapies for Hepatocellular Cancer
Q53220944Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.
Q30398077Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers
Q89623948Comparison of the current international guidelines on the management of HCC
Q48092299Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.
Q99248392Development of machine learning-based clinical decision support system for hepatocellular carcinoma
Q48592959External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study. (HEP-17-0903).
Q57482215Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
Q37096406Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru.
Q36951503In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer
Q92648957Laparoscopic hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis
Q26749329New advances in hepatocellular carcinoma
Q38560093Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma
Q49164405Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma
Q38283649State of the art: hepatocellular carcinoma
Q47320493Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study
Q38295870Treatment of hepatocellular carcinoma: beyond international guidelines.
Q38685608Treatment of hepatocellular carcinoma: beyond international guidelines.

Search more.